MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14134662

Медицинская библиотека · Journal of clinical medicine · 2025

Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6.

Ippolito Edy, Toppi Lucrezia, Carrafiello Sofia, Greco Carlo, Fiore Michele, Alaimo Rita, Minuti Salvatore, Pantano Francesco, Casale Giuseppe, D'Angelillo Rolando Maria, Turriziani Adriana, De Marinis Maria Grazia, Ramella Sara

СтатьяПеревод в очереди

Аннотация

Background

CDK4/6 inhibitor plus ET is a standard treatment for advanced HR+ BC. This study evaluates the efficacy and safety of CDK4/6 inhibitors with concurrent RT (SBRT and non-SBRT) in terms of pain, analgesic therapy changes, toxicities, and net clinical benefit (NCB).

Methods

BC patients with bone metastases treated with RT and CDK4/6 inhibitor in the prospective observational COMBART study were analyzed. Pain was measured with the NRS. The NCB was defined by pain reduction (NRS), toxicity, and treatment changes. Adverse events (AEs) were graded per CTCAE v5.0. Statistical tests included chi-square and t-test.

Results

Forty patients were treated with CDK4/6 inhibitor (palbociclib 30.8%, ribociclib 51.3%, abemaciclib 17.9%) and RT (131 lesions; 100 SBRT, 31 non-SBRT). The mean NRS score dropped from 3.52 (pre-treatment) to 1.31 (post-treatment) (p < 0.001), with better outcomes for patients treated with moderate hypofractionation (58.6% vs. 39.9% pain relief, p = 0.016). Pain relief was independent of the type of CDK4/6 inhibitor used (p = NS). Analgesic reduction was most common with palbociclib (35.4%, p = 0.001). Eight toxicities (grade 1-2) were reported. The NCB was 0.6 overall, higher with non-SBRT (0.74 vs. 0.52).

Conclusions

RT plus CDK4/6 inhibitor, especially with moderate hypofractionation, significantly reduced pain with manageable toxicity. Analgesic therapy can often continue without stopping CDK4/6 inhibitor.

Для цитирования: Ippolito Edy, Toppi Lucrezia, Carrafiello Sofia, Greco Carlo, Fiore Michele, Alaimo Rita, Minuti Salvatore, Pantano Francesco, Casale Giuseppe, D'Angelillo Rolando Maria, Turriziani Adriana, De Marinis Maria Grazia, Ramella Sara. Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14134662.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.